Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Voyager Therapeut (NQ: VYGR )

6.340 +0.140 (+2.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 425,010
Open 6.645
Bid (Size) 6.190 (1)
Ask (Size) 6.790 (1)
Prev. Close 6.200
Today's Range 6.230 - 6.645
52wk Range 6.060 - 11.72
Shares Outstanding 54,533,254
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 High-Growth Stocks Poised To Double By Next Year
The article outlines three high-growth stocks that could double by 2025, using specific screening criteria: strong buy ratings from multiple analysts, significant revenue and earnings growth, and... 
Via Talk Markets
7 Biotech Stocks to Buy for Their Game-Changing Potential
Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks. 
Via InvestorPlace

Performance

YTD
-29.56%
-29.56%
1 Month
-22.59%
-22.59%
3 Month
-25.24%
-25.24%
6 Month
-32.84%
-32.84%
1 Year
-32.48%
-32.48%

More News

Read More
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
What Analysts Are Saying About Voyager Therapeutics Stock
Via Benzinga
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing?
Via Chartmill
Is NASDAQ:VYGR a Fit for Growth Investing Strategies?
Via Chartmill
Delving into NASDAQ:VYGR's Growth Prospects.
Via Chartmill
Exploring NASDAQ:VYGR's growth characteristics.
Via Chartmill
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
Via InvestorPlace
Cheap Thrills: 7 Promising Value Stocks You Can Buy for Under $20
Via InvestorPlace
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
Via Benzinga
Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing?
Via Chartmill
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Voyager Therapeutics: Q4 Earnings Insights
Via Benzinga
Earnings Preview For Voyager Therapeutics
Via Benzinga
Earnings Scheduled For February 28, 2024
Via Benzinga
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
Via InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Financial Frontrunners: 3 Stocks Where the Big Money Is Moving in 2024
Via InvestorPlace
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Voyager Therapeutics stock pops 30% on deal with Novartis
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.